The complexity of signaling pathways activated by the BCR

Current Opinion in Immunology

Volumn 9, Issue 3, 1997, Pages 296-308

  DeFranco, Anthony L ^a  

^a George W Hooper Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN TYROSINE KINASE;

B LYMPHOCYTE; ENZYME ACTIVATION; REVIEW;

EID: 0030831199     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80074-X     Document Type: Article

References (120)

1. Roth PE, DeFranco AL. Lymphocyte development: intrinsic checkpoints for maturation. Curr Biol. 5:1995;349-352.
2. Cheng AM, Rowley B, Pao W, Hayday A, Bolen JB, Pawson T. Syk tyrosine kinase required for mouse viability and B-cell development. Nature. 378:1995;303-306.
3. syk. Nature. 378:1995;298-302.
4. Nemazee D. Can receptor editing play an important role in normal B-cell development? J Autoimmun. 9:1996;259-261.
5. Goodnow CC. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. of special interest Proc Natl Acad Sci USA. 93:1996;2264-2271 An excellent review of the consequences of BCR signaling and the influences on it.
6. Bolen JB. Protein tyrosine kinases in the initiation of antigen receptor signaling. Curr Opin Immunol. 7:1995;306-311.
7. Rawlings DJ, Scharenberg AM, Park H, Wahl MI, Lin S, Kato RM, Fluckiger AC, Witte ON, Kinet JP. Activation of Btk by a phosphorylation mechanism initiated by Src family kinases. Science. 271:1996;822-825.
8. DeFranco AL. Transmembrane signaling by antigen receptors of B and T lymphocytes. Curr Opin Cell Biol. 7:1995;163-175.
9. Chan AC, Shaw AS. Regulation of antigen receptor signal transduction by protein tyrosine kinases. Curr Opin Immunol. 8:1996;394-401.
10. Pawson T. Protein modules and signalling networks. Nature. 373:1995;573-580.
11. Fantl WJ, Johnson DE, Williams LT. Signalling by receptor tyrosine kinases. Annu Rev Biochem. 62:1993;453-481.
12. Songyang Z, Cantley L. Recognition and specificity in protein tyrosine kinase-mediated signalling. Trends Biochem Sci. 20:1995;470-475.
13. Bijsterbosch MK, Meade CJ, Turner GA, Klaus GGB. B lymphocyte receptors and polyphosphoinositide degradation. Cell. 41:1985;999-1006.
14. Lund F, Solvason N, Grimaldi JC, Parkhouse RM, Howard M. Murine CD38: an immunoregulatory ectoenzyme. Immunol Today. 16:1995;469-473.
15. Lund FE, Yu N, Kim KM, Reth M, Howard MC. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. J Immunol. 157:1996;1455-1467.
16. DeFranco AL. Structure and function of the B cell antigen receptor. Annu Rev Cell Biol. 9:1993;377-410.
17. Kim K-M, Ishigami T, Hata D, Yamaoka K, Mayumi M, Mikawa M, Mikawa H. Regulation of cell division of mature B cells by ionomycin and phorbol ester. J Immunol. 148:1992;1797-1803.
18. Muthukkumar S, Udhayakumar V, Bondada S. Elevation of cytosolic calcium is sufficient to induce growth inhibition in a B cell lymphoma. Eur J Immunol. 23:1993;2419-2426.
19. Foote LC, Schneider TJ, Fischer GM, Wang JK, Rasmussen B, Campbell KA, Lynch DH, Ju ST, Marshak-Rothstein A, Rothstein TL. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells. of outstanding interest J Immunol. 157:1996;1878-1885 An examination of the signaling events that mediate the ability of BCR signaling to protect CD40-stimulated B cells from Fas-mediated apoptosis.
20. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stabel S, Tarakhovsky A. Immunodeficiency in protein kinase C β-deficient mice. of outstanding interest Science. 273:1996;788-791 Characterization of antibody responses as being deficient in mice lacking PKC-β.
21. Xie H, Rothstein TL. Protein kinase C mediates activation of nuclear cAMP response element-binding protein (CREB) in B lymphocytes stimulated through surface Ig. J Immunol. 154:1995;1717-1723.
22. Xie H, Wang Z, Rothstein T. Signaling pathways for antigen receptor-mediated induction of transcription factor CREB in B lymphocytes. Cell Immunol. 169:1996;264-270.
23. Gold MR, Sanghera JS, Stewart J, Pelech SL. Selective activation of p42 MAP kinase in murine B lymphoma cell lines by membrane immunoglobulin crosslinking. Evidence for protein kinase C-independent and -dependent mechanisms of activation. Biochem J. 286:1992;269-276.
24. Sidorenko SP, Law C-L, Klaus SJ, Chandran KA, Takata M, Kurosaki T, Clark EA. Protein kinase Cμ (PKCμ) associates with the B cell antigen receptor complex and regulates lymphocyte signaling. of special interest Immunity. 5:1996;353-363 This paper demonstrates that, remarkably, PKC μ associates with the BCR. Furthermore, PKCμ is activated upon BCR stimulation and this activation appears to result as a consequence of DAG production. In addition, the experiments described suggest that a target of PKCμ is Syk, reflecting feedback inhibition.
25. Valentine MA, Czernik AJ, Rachie N, Hidaka H, Fisher CL, Cambier JC, Bomsztyk K. Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes. J Exp Med. 182:1995;1943-1949.
26. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today. 13:1992;136-142.
27. Fisher CL, Ghysdael J, Cambier JC. Ligation of membrane Ig leads to calcium-mediated phosphorylation of the proto-oncogene product Ets-1. J Immunol. 146:1991;1743-1749.
28. Venkataraman L, Francis DA, Wang Z, Liu J, Rothstein TL, Sen R. Cyclosporin-A sensitive induction of NF-AT in murine B cells. Immunity. 1:1994;189-196.
29. Genestier L, Dearden-Badet MT, Bonnefoy-Berard N, Lizard G, Revillard JP. Cyclosporin A and FK506 inhibit activation-induced death in the murine WEHI-231 B cell line. Cell Immunol. 155:1994;283-291.
30. O'Garra A, Warren DJ, Holman M, Popham AM, Sanderson CJ, Klaus GG. Effects of cyclosporin on responses of murine B cells to T cell-derived lymphokines. J Immunol. 137:1986;2220-2224.
31. DeFranco AL. Signaling pathways activated by protein tyrosine phosphorylation in lymphocytes. Curr Opin Immunol. 6:1994;364-371.
32. 2+ mobilization through distinct pathways. EMBO J. 13:1994;1341-1349.
33. Takata M, Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ2. of outstanding interest J Exp Med. 184:1996;31-40 Demonstrates a critical role for Btk in the activation of PLC-γ by the BCR.
34. Law CL, Sidorenko SP, Chandran KA, Zhao Z, Shen SH, Fischer EH, Clark EA. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-γ1 upon B cell activation. J Exp Med. 183:1996;547-560.
35. O'Keefe TL, Williams GT, Davies SL, Neuberger MS. Hyperresponsive B cells in CD22-deficient mice. of special interest Science. 274:1996;798-801 Characterization of the B cells from mice lacking CD22. BCR-induced calcium elevation is enhanced in the absence of CD22. In [36-38] antibody or proliferative responses to BCR engagement are found to be decreased. Thus, CD22 functions both positively and negatively in modulating responses to antigen.
36. Otipoby KL, Andersson KB, Draves KE, Klaus SJ, Farr AG, Kerner JD, Perlmutter RM, Law CL, Clark EA. CD22 regulates thymus-independent responses and the lifespan of B cells. of special interest Nature. 384:1996;634-637 See annotation [35].
37. Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang ML, Tedder TF. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. of special interest Immunity. 5:1996;551-562 See annotation [35].
38. Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC. CD22 is a negative regulator of B-cell receptor signalling. of special interest Curr Biol. 7:1997;133-143 See annotation [35].
39. syk with the src-homology-2 (SH2) domains of PLC-γ1 in B lymphocytes. J Biol Chem. 270:1995;11806-11811.
40. Law CL, Chandran KA, Sidorenko SP, Clark EA. Phospholipase C-γ1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol Cell Biol. 16:1996;1305-1315.
41. Sieh M, Batzer A, Schlessinger J, Weiss A. GRB2 and phospholipase C-γ1 associate with a 36- to 38-kilodalton phosphotyrosine protein after T-cell receptor stimulation. Mol Cell Biol. 14:1994;4435-4442.
42. Motto DG, Musci MA, Ross SE, Koretzky GA. Tyrosine phosphorylation of Grb2-associated proteins correlates with phospholipase C γ1 activation in T cells. Mol Cell Biol. 16:1996;2823-2829.
43. Huang X, Li Y, Tanaka K, Moore KG, Hayashi JI. Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase Cγ1, Grb2, and phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA. 92:1995;11618-11622.
44. ras and RasGAP signaling pathway. J Exp Med. 178:1993;1765-1769.
45. ras. J Immunol. 151:1993;4513-4522.
46. McMahon SB, Monroe JG. A ternary complex factor-dependent mechanism mediates induction of egr-1 through selective serum response elements following antigen receptor crosslinking in B lymphocytes. Mol Cell Biol. 15:1995;1086-1093.
47. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol. 8:1996;205-215.
48. Maltzman J, Monroe JG. A role for EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes. of special interest Mol Cell Biol. 16:1996;2283-2294 Demonstrates that the CD44 gene is activated by the Egr1 transcription factor in BCR-stimulated B cells.
49. Maltzman J, Monroe JG. Transcriptional regulation of the ICAM-1 gene in antigen receptor and phorbol ester stimulated B lymphocytes: role for transcription factor EGR1. of special interest J Exp Med. 183:1996;1747-1759 Demonstrates that the ICAM-1 gene is activated by the Egr1 transcription factor in BCR-stimulated B cells.
50. ras pathway couples antigen receptor stimulation to induction of the primary response gene egr-1 in B lymphocytes. J Exp Med. 181:1995;417-422.
51. 2 hydrolysis was not, perhaps suggesting that one or more additional lymphoid-specific signaling components are required for this response.
52. res oncoprotein activators SHC and mSOS1 as well as assembly of complexes containing SHC, GRB-2, mSOS1 and a 145-kDa tyrosine-phosphorylated protein. J Immunol. 153:1994;623-636.
53. Lankester AC, van Schijndel GM, Rood PM, Verhoeven AJ, van Lier RA. B cell antigen receptor cross-linking induces tyrosine phosphorylation and membrane translocation of a multimeric Shc complex that is augmented by CD19 co-ligation. Eur J Immunol. 24:1994;2818-2825.
54. Smit L, de Vries-Smits AMM, Bos JL, Borst J. B cell antigen receptor stimulation induces formation of a Shc-Grb2 complex containing multiple tyrosine-phosphorylated proteins. J Biol Chem. 269:1994;20209-20212.
55. Holsinger LJ, Spencer DM, Austin DJ, Schreiber SL, Crabtree GR. Signal transduction in T lymphocytes using a conditional allele of Sos. Proc Natl Acad Sci USA. 92:1995;9810-9814.
56. Ravichandran KS, Lee KK, Songyang Z, Cantley LC, Burn P, Burakoff SJ. Interaction of Shc with the ζ chain of the T cell receptor upon T cell activation. Science. 262:1993;902-905.
57. Baumann G, Maier D, Freuler F, Tschopp C, Baudisch K, Wienands J. In vitro characterization of major ligands for Src homology 2 domains derived from protein tyrosine kinases, from the adapter protein SHC and from GTPase-activating protein in Ramos B cells. Eur J Immunol. 24:1994;1799-1807.
58. D'Ambrosio D, Hippen KL, Cambier JC. Distinct mechanisms mediate SHC association with the activated and resting B cell antigen receptor. Eur J Immunol. 26:1996;1960-1965.
59. Nagai K, Takata M, Yamamura H, Kurosaki T. Tyrosine phosphorylation of Shc is mediated through Lyn and Syk in B cell receptor signaling. J Biol Chem. 270:1995;6824-6829.
60. Ravichandran KS, Lorenz U, Shoelson SE, Burakoff SJ. Interaction of Shc with Grb2 regulates association of Grb2 with mSOS. Mol Cell Biol. 15:1995;593-600.
61. Reedquist KA, Fukazawa T, Panchamoorthy G, Langdon WY, Shoelson SE, Druker BJ, Band H. Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J Biol Chem. 271:1996;8435-8442.
62. Harmer S, DeFranco AL. Shc possesses two Grb2 binding sites needed for the efficient formation of complexes with SOS in B lymphocytes. Mol Cell Biol. 1997;. in press.
63. McCormick F. Activators and effectors of ras p21 proteins. Curr Opin Genet Dev. 4:1994;71-76.
64. McCormick F, Wittinghofer A. Interactions between Ras proteins and their effectors. Curr Opin Biotechnol. 7:1996;449-456.
65. ras GTPase-activating protein (GAP) and two GAP-associated proteins. J Immunol. 150:1993;377-386.
66. Settleman J, Albright CF, Foster LC, Weinberg RA. Association between GTPase activators for Rho and Ras families. Nature. 359:1992;153-154.
67. dok: a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell. 88:1997;197-204.
68. Yamanashi Y, Baltimore D. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein Dok. Cell. 88:1997;205-211.
69. Beckwith M, Fenton RG, Katona IM, Longo DL. Phosphatidylinositol-3-kinase activity is required for the anti-Ig-mediated growth inhibition of a human B-lymphoma cell line. of special interest Blood. 87:1996;202-210 Wortmannin is found to inhibit BCR-induced growth inhibition in the RL B cell line indicating an important role for PI3-K.
70. Tuveson DA, Carter RH, Soltoff SP, Fearon DT. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science. 260:1993;986-989.
71. Fearon DT, Carter RH. The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity. Annu Rev Immunol. 13:1995;127-149.
72. Pleiman CM, Hertz WM, Cambier JC. Activation of phosphatidylinositol-3'kinase by Src-family kinase SH3 binding to the p85 subunit. Science. 263:1994;1609-1612.
73. Yamanashi Y, Fukui Y, Wongsasant B, Kinoshita Y, Ichimori Y, Toyoshima K, Yamamoto T. Activation of Src-like protein-tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon B-cell antigen receptor-mediated signaling. Proc Natl Acad Sci USA. 89:1992;1118-1122.
74. fyn domains associate with nonphosphorylated and phosphorylated Ig-α Proc Natl Acad Sci USA. 91:1994;4268-4272.
75. Law DA, Chan VWF, Datta SK, DeFranco AL. B-cell antigen receptor motifs have redundant signalling capabilities and bind the tyrosine kinases PTK72, Lyn and Fyn. Curr Biol. 3:1993;645-657.
76. Beckwith M, Jorgensen G, Longo DL. The protein product of the proto-oncogene c-cbl forms a complex with phosphatidylinositol 3-kinase p85 and CD19 in anti-IgM-stimulated human B lymphoma cells. of special interest Blood. 88:1996;3502-3507 Evidence for the association of Cbl with CD19, possibly in a multimeric complex involving PI3-K.
77. Gold MR, Aebersold R. Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells. J Immunol. 152:1994;42-50.
78. SHIP and its association with Shc and with Syk.
79. Chacko GW, Tridandapani S, Damen JE, Liu L, Krystal G, Coggeshall KM. Negative signaling in B lymphocytes induces tyrosine phosphorylation of the 145-kDa inositol polyphosphate 5-phosphatase, SHIP. of outstanding interest J Immunol. 157:1996;2234-2238 Demonstrates that SHIP is more strongly phosphorylated when the BCR is co-ligated to FcγRIIB1 than when the BCR is simply cross-linked. This result suggests that SHIP participates in negative regulation by FcγRIIB1.
80. 3, rather than to other phosphoinositides.
81. 2 breakdown induced by the BCR and demonstrates it is not due to a general inhibition of BCR signaling.
82. Bijsterbosch MK, Klaus GGB. Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptor. J Exp Med. 162:1985;1825-1836.
83. Franke TF, Kaplan DR, Cantley LC, Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science. 275:1997;665-668.
84. Klippel A, Kavanaugh WM, Pot D, Williams LT. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol Cell Biol. 17:1997;338-344.
85. Wange RL, Samelson LE. Complex complexes: signaling at the TCR. Immunity. 5:1996;197-205.
86. Lupher ML Jr, Reedquist KA, Miyake S, Langdon WY, Band H. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells. J Biol Chem. 271:1996;24063-24068.
87. Cory GO, Lovering RC, Hinshelwood S, MacCarthy-Morrogh L, Levinsky RJ, Kinnon C. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J Exp Med. 182:1995;611-615.
88. Hartley D, Meisner H, Corvera S. Specific association of the β isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl. J Biol Chem. 270:1995;18260-18263.
89. cbl in antigen receptor-ligated B cells. J Biol Chem. 270:1995;27504-27509.
90. cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem. 271:1996;3187-3194.
91. of outstanding interest Smit L, van der Horst G, Borst J. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors. of special interest J Biol Chem. 271:1996;8564-8569 This reference, along with [92] establishes a role for Cbl in the formation of complexes containing the nucleotide exchange factor C3G, providing a model for how Cbl might function as an inhibitor of the Ras pathway.
92. of special interest Ingham RJ, Krebs DL, Barbazuk SM, Turck CW, Hirai H, Matsuda M, Gold MR. B cell antigen receptor signaling induces the formation of complexes containing the Crk adapter proteins. of outstanding interest J Biol Chem. 271:1996;32306-32314 See annotation [91].
93. Yoon CH, Lee J, Jongeward GD, Sternberg PW. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science. 269:1995;1102-1105.
94. lyn, in the B cell antigen receptor-mediated signaling. of special interest J Exp Med. 183:1996;675-680 Demonstrates that Lyn is required in the DT-40 chicken B cell line for the BCR to phosphorylate Cbl.
95. Bonnefoy-Berard N, Munshi A, Yron I, Wu S, Collins TL, Deckert M, Shalom-Barak T, Giampa L, Herbert E, Hernandez J, et al. Vav: function and regulation in hematopoietic cell signaling. of special interest Stem Cells. 14:1996;250-268 A thoughtful and balanced review of the function of Vav and its role in antigen receptor signaling.
96. Olson MF, Pasteris NG, Gorski JL, Hau A. Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases. Curr Biol. 6:1996;1628-1633.
97. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature. 385:1997;169-172.
98. Kyriakis JM, Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem. 271:1996;24313-24316.
99. Berberich I, Shu G, Siebelt F, Woodgett JR, Kyriakis JM, Clark EA. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. of special interest EMBO J. 15:1996;92-101 Demonstrates that CD40 and the BCR activate the JNK and p38 MAP kinases. See also [100].
100. Sutherland CL, Heath AW, Pelech SL, Young PR, Gold MR. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. of special interest J Immunol. 157:1996;3381-3390 See annotation [99].
101. Graves JD, Draves KE, Craxton A, Saklatvala J, Krebs EG, Clark EA. Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. of special interest Proc Natl Acad Sci USA. 93:1996;13814-13818 Evidence for a role for JNK and p38 MAP kinases in BCR-induced apoptosis.
102. Tanguay DA, Dickinson JA, McManus BJ, Huo L, Rothstein TL, Chiles TC. Activation of AP-1 in primary B lymphocytes by surface immunoglobulin requires de novo Jun-B synthesis. Cell Immunol. 158:1994;281-291.
103. vav activity. Mol Cell Biol. 15:1995;4337-4346.
104. Jain J, Loh C, Rao A. Transcriptional regulation of the IL-2 gene. Curr Opin Immunol. 7:1995;333-342.
105. Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. of special interest Immunity. 5:1996;591-604 Provides evidence for an important functional interaction between Syk and Vav.
106. Weng W-K, Jarvis L, LeBien TW. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem. 269:1994;32514-32521.
107. Yamanashi Y, Okada M, Semba T, Yamori T, Umemori H, Tsunasawa S, Toyoshima K, Kitamura D, Watanabe T, Yamamoto T. Identification of HS1 protein as a major substate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. Proc Natl Acad Sci USA. 90:1993;3631-3635.
108. Taniuchi I, Kitamura D, Maekawa Y, Fukuda T, Kishi H, Watanabe T. Antigen-receptor induced clonal expansion and deletion of lymphocytes are impaired in mice lacking HS1 protein, a substrate of the antigen-receptor-coupled tyrosine kinases. EMBO J. 14:1995;3664-3678.
109. Fukuda T, Kitamura D, Taniuchi I, Maekawa Y, Benghamou LE, Sarthou P, Watanabe T. Restoration of surface IgM-mediated apoptosis in an anti-IgM-resistant variant of WEHI-231 lymphoma cells by HS1, a protein-tyrosine kinase substrate. Proc Natl Acad Sci USA. 92:1995;7302-7306.
110. Dempsey PW, Allison MED, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. of outstanding interest Science. 271:1996;348-350 Demonstrates the dramatic enhancing effect of co-engagement of the BCR and CR2 on B cell antibody responses in vivo.
111. Ono M, Bolland S, Tempst P, Ravetch JV. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. of outstanding interest Nature. 383:1996;263-266 Demonstrates that SHIP binds to and is an important mediator of the negative signaling effects of FcγRIIB.
112. D'Ambrosio D, Hippen KH, Minskoff SA, Mellman I, Pani G, Siminovitch KA, Cambier JC. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIB1. Science. 268:1995;293-297.
113. Ashman RF, Peckham D, Stunz LL. Fc receptor off-signal in the B cell involves apoptosis. of special interest J Immunol. 157:1996;5-11 Demonstrates that co-engagement of FcγRIIb with the BCR leads to apoptosis, that is, a negative response rather than just ignorance of the binding as might be expected if the FcR simply blocked BCR signaling events. This suggests that only some BCR signaling events are blocked and that the remaining signals induce apoptosis.
114. Tridandapani S, Chacko GW, Van Brocklyn JR, Coggeshall KM. Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions. of special interest J Immunol. 158:1997;1125-1132 Demonstrates that FcγRIIB1 inhibits Ras activation by the BCR.
115. Huo L, Rothstein TL. Receptor-specific induction of individual AP-1 components in B lymphocytes. J Immunol. 154:1995;3300-3309.
116. Tanguay D, Chiles T. Cell cycle-specific induction of cdk2 expression in B lymphocytes following antigen receptor cross-linking. Mol Immunol. 31:1994;643-649.
117. PKS-J3/cdk4) for the major D-type cyclin in mature B lymphocytes. J Immunol. 156:1996;539-548.
118. Solvason N, Wu W, Kabra N, Wu X, Lees E, Howard M. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. of special interest J Exp Med. 184:1996;407-417 This paper examines the expression of important cell cycle regulatory proteins involved in BCR-induced B cell proliferation.
119. Horne MC, Donaldson KL, Goolsby GL, Tran D, Mulheisen M, Hell JW, Wahl AF. Cyclin G2 is upregulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest. J Biol Chem. 272:1997;12650-12661.
120. Chan VWF, Meng F, Soriano P, DeFranco AL, Lowell CA. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and downregulation. Immunity. 7:1997;. in press.